Progression of coronary artery calcification is associated with long-term cadiovascular events in hypertensive adults

被引:8
作者
Shemesh, Joseph [1 ,6 ,7 ]
Motro, Michael [1 ,6 ,7 ]
Grossman, Chagai [2 ,3 ,6 ,7 ]
Morag-Koren, Nira [4 ,7 ]
Apter, Sara [5 ,6 ,7 ]
Grossman, Ehud [2 ,3 ,6 ,7 ]
机构
[1] Cardiac Rehabil Inst, Grace Ballas Res Unit, Tel Hashomer, Israel
[2] Dept Internal Med D, Tel Hashomer, Israel
[3] Hypertens Unit, Tel Hashomer, Israel
[4] Dept Epidemiol & Prevent Med, Tel Hashomer, Israel
[5] Dept Diagnost Imaging, Tel Hashomer, Israel
[6] Chaim Sheba Med Ctr, IL-52621 Tel Hashomer, Israel
[7] Tel Aviv Univ, Sackler Fac Med, IL-69978 Tel Aviv, Israel
关键词
cardiovascular events; coronary calcification; hypertension; progression of coronary calcification; BEAM COMPUTED-TOMOGRAPHY; CALCIUM-CHANNEL BLOCKER; MYOCARDIAL-INFARCTION; RISK-FACTORS; FOLLOW-UP; ASYMPTOMATIC SUBJECTS; CARDIOVASCULAR RISK; ANGINA-PECTORIS; HEART-DISEASE; ATHEROSCLEROSIS;
D O I
10.1097/HJH.0b013e328362b9f8
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
Objectives:Coronary artery calcification (CAC) is an independent predictor of cardiovascular (CV) events in hypertensive adults. However, the additive value of serial CAC measurements for risk stratification is unclear. The aim of the present study was to find whether CAC progression predicts long-term CV events in hypertensive patients.Methods:The study group included 210 patients (mean age 645.6 years, 54% men), a subgroup of 544 participants in the calcification side arm of the INSIGHT (International Nifedipine Study Intervention as Goal for Hypertension Therapy). All were free of symptoms or known CV disease, had at least two CT scans 1 year apart, and had available long-term follow-up. Progression of CAC was defined as the absolute change in CAC score between maximal score during follow-up and baseline score. The endpoint was the first CV event after the last CT scan. Three categories of CAC progression were defined. Zero progression was defined as nonprogressors', and progression below and above the median of maximal progression were defined as slow progressors' and rapid progressors', respectively.Results:During 15 years of follow-up (mean 11.4 +/- 4.4), 83 patients experienced a first CV event. The rate of events was higher in rapid (29/59, 49%), and slow (36/78 46%) than in nonprogressors (18/73 25%); (P=0.005). Compared with nonprogressors, the adjusted hazard ratio for CV events was 1.91 [95% confidence interval (95% CI); 1.05-3.47] in the slow, and 2.13 (95% CI; 1.12-4.03) in the rapid progressors.Conclusion:In hypertensive patients, progression of CAC is associated with long-term CV events.
引用
收藏
页码:1886 / 1892
页数:7
相关论文
共 37 条
[1]   Coronary calcification, coronary disease risk factors, C-reactive protein, and atherosclerotic cardiovascular disease events - The St. Francis Heart Study [J].
Arad, Y ;
Goodman, KJ ;
Roth, M ;
Newstein, D ;
Guerci, AD .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2005, 46 (01) :158-165
[2]   Effects of sevelamer and calcium on coronary artery calcification in patients new to hemodialysis [J].
Block, GA ;
Spiegel, DM ;
Ehrlich, J ;
Mehta, R ;
Lindbergh, J ;
Dreisbach, A ;
Raggi, P .
KIDNEY INTERNATIONAL, 2005, 68 (04) :1815-1824
[3]   Measurement of coronary artery calcium with dual-slice helical CT compared with coronary angiography: Evaluation of CT scoring methods, interobserver variations, and reproducibility [J].
Broderick, LS ;
Shemesh, J ;
Wilensky, RL ;
Eckert, GJ ;
Zhou, XH ;
Torres, WE ;
Balk, MA ;
Rogers, WJ ;
Conces, DJ ;
Kopecky, KK .
AMERICAN JOURNAL OF ROENTGENOLOGY, 1996, 167 (02) :439-444
[4]   Morbidity and mortality in patients randomised to double-blind treatment with a long-acting calcium-channel blocker or diuretic in the International Nifedipine GITS study: Intervention as a Goal in Hypertension Treatment (INSIGHT) [J].
Brown, MJ ;
Palmer, CR ;
Castaigne, A ;
de Leeuw, PW ;
Mancia, G ;
Rosenthal, T ;
Ruilope, LM .
LANCET, 2000, 356 (9227) :366-372
[5]   Progression of Coronary Artery Calcium Predicts All-Cause Mortality [J].
Budoff, Matthew J. ;
Hokanson, John E. ;
Nasir, Khurram ;
Shaw, Leslee J. ;
Kinney, Gregory L. ;
Chow, David ;
DeMoss, Daniel ;
Nuguri, Vivek ;
Nabavi, Vahid ;
Ratakonda, Raghu ;
Berman, Daniel S. ;
Raggi, Paolo .
JACC-CARDIOVASCULAR IMAGING, 2010, 3 (12) :1229-1236
[6]   Tracking progression of heart disease with cardiac computed tomography [J].
Budoff, MJ .
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY AND THERAPEUTICS, 2004, 9 (02) :75-82
[7]   Effect of HMG-Coa reductase inhibitors on coronary artery disease as assessed by electron-beam computed tomography [J].
Callister, TQ ;
Raggi, P ;
Cooil, B ;
Lippolis, NJ ;
Russo, DJ .
NEW ENGLAND JOURNAL OF MEDICINE, 1998, 339 (27) :1972-1978
[8]   Association Between Coronary Artery Calcification Progression and Microalbuminuria The MESA Study [J].
DeFilippis, Andrew P. ;
Kramer, Holly J. ;
Katz, Ronit ;
Wong, Nathan D. ;
Bertoni, Alain G. ;
Carr, Jeffrey ;
Budoff, Matthew J. ;
Blumenthal, Roger S. ;
Nasir, Khurram .
JACC-CARDIOVASCULAR IMAGING, 2010, 3 (06) :595-604
[9]   Coronary calcium as a predictor of coronary events in four racial or ethnic groups [J].
Detrano, Robert ;
Guerci, Alan D. ;
Carr, J. Jeffrey ;
Bild, Diane E. ;
Burke, Gregory ;
Folsom, Aaron R. ;
Liu, Kiang ;
Shea, Steven ;
Szklo, Moyses ;
Bluemke, David A. ;
O'Leary, Daniel H. ;
Tracy, Russell ;
Watson, Karol ;
Wong, Nathan D. ;
Kronmal, Richard A. .
NEW ENGLAND JOURNAL OF MEDICINE, 2008, 358 (13) :1336-1345
[10]   Coronary Risk Stratification, Discrimination, and Reclassification Improvement Based on Quantification of Subclinical Coronary Atherosclerosis The Heinz Nixdorf Recall Study [J].
Erbel, Raimund ;
Moehlenkamp, Stefan ;
Moebus, Susanne ;
Schmermund, Axel ;
Lehmann, Nils ;
Stang, Andreas ;
Dragano, Nico ;
Groenemeyer, Dietrich ;
Seibel, Rainer ;
Kaelsch, Hagen ;
Broecker-Preuss, Martina ;
Mann, Klaus ;
Siegrist, Johannes ;
Joeckel, Karl-Heinz .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2010, 56 (17) :1397-1406